• Profile
Close

Do oral ovulation induction agents offer benefits in women 38 to 43 years of age undergoing insemination cycles?

European Journal of Obstetrics & Gynecology and Reproductive Biology Jan 15, 2021

Steiner N, Ruiter-Ligeti J, Frank R, et al. - The success of ovulation induction using oral agents vs gonadotropins (GTs) was determined in women ≥ 38 years old. In this retrospective cohort study, researchers included all first to third stimulated IUI cycles performed after the age of 38 years in a single academic fertility center between January 2011 and March 2018. Of 1,596 included IUI cycles, 240 cycles were with clomiphene citrate (CC), 176 were letrozole cycles and 1,180 were gonadotropin (GTs) cycles. The 3-groups exhibited no difference in pregnancy or clinical pregnancy rates after controlling for confounders. Relative to GTs, oral agents incurred lower costs and are more patient friendly, hence, oral agents should be first line for ovarian stimulation and IUI in women 38-43-years of age.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay